Butylhydroxybutylnitrosamine
"Butylhydroxybutylnitrosamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A substituted carcinogenic nitrosamine.
| Descriptor ID |
D002085
|
| MeSH Number(s) |
D02.654.442.100
|
| Concept/Terms |
Butylhydroxybutylnitrosamine- Butylhydroxybutylnitrosamine
- N-Nitrosobutyl-4-hydroxybutylamine
- N Nitrosobutyl 4 hydroxybutylamine
- N-Nitroso-N-butyl-(4-hydroxybutyl)amine
- Butylbutanolnitrosamine
- N-Butyl-N-(4-hydroxybutyl)nitrosamine
|
Below are MeSH descriptors whose meaning is more general than "Butylhydroxybutylnitrosamine".
Below are MeSH descriptors whose meaning is more specific than "Butylhydroxybutylnitrosamine".
This graph shows the total number of publications written about "Butylhydroxybutylnitrosamine" by people in this website by year, and whether "Butylhydroxybutylnitrosamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Butylhydroxybutylnitrosamine" by people in Profiles.
-
Nishizawa K, Nishiyama H, Oishi S, Tanahara N, Kotani H, Mikami Y, Toda Y, Evans BJ, Peiper SC, Saito R, Watanabe J, Fujii N, Ogawa O. Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4. Int J Cancer. 2010 Sep 1; 127(5):1180-7.
-
Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis. 2008 Apr; 29(4):846-8.
-
Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ, Grubbs CJ. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis. 2005 Mar; 26(3):571-8.
-
Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R. Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res. 2004 Nov 15; 10(22):7607-12.